Short Interest in Arbutus Biopharma Co. (NASDAQ:ABUS) Expands By 6.7%

Arbutus Biopharma Co. (NASDAQ:ABUS – Get Free Report) was the target of a large growth in short interest in November. As of November 15th, there was short interest totalling 6,730,000 shares, a growth of 6.7% from the October 31st total of 6,310,000 shares. Based on an average daily volume of 637,700 shares, the short-interest ratio […]

Leave a Reply

Your email address will not be published.

Previous post Addex Therapeutics Ltd (NASDAQ:ADXN) Short Interest Up 5.7% in November
Next post Analysts Set Sovos Brands, Inc. (NASDAQ:SOVO) Target Price at $22.28